FutureChem Co.,Ltd (KOSDAQ:220100)

Market Cap	473.11B -14.2%
Revenue (ttm)	18.67B +8.0%
Net Income	-11.25B
EPS	-508.00
Shares Out	22.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,737
Average Volume	179,474
Open	21,300
Previous Close	21,000
Day's Range	20,800 - 21,600
52-Week Range	14,900 - 35,050
Beta	0.65
RSI	44.15
Earnings Date	Mar 24, 2026

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 220100

Financial Performance

In 2025, FutureChem Co.,Ltd's revenue was 18.67 billion, an increase of 7.96% compared to the previous year's 17.29 billion. Losses were -11.25 billion, 19.5% more than in 2024.